Cambridge-based Biogen will stop developing its controversia

Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple years ago.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Japan , Japanese , , Drug Administration , Biogen Inc , Massachusetts Based Biogen , Alzheimers Disease , Biogen , Alzheimers Treatment , Food And Drug Administration , Blockbuster Drug ,